In the StatesMASSACHUSETTS: NLARx Members Montigny and Moore Defend Gift-Ban Bill Skewered by Biotech Industry More
FLORIDA: Another Push to Limit Generics More
NEW YORK: Detailer Registration Bill Clears Committee More
HAWAII: Legislature Overrides Gov. Lingle's Veto of Prescription Drug Importation Program More
TEXAS: Preferred Drug List Saves Texas $116 Million More
NEBRASKA: PDL Allows State to Negotiate Prices with Drug Companies More
CONNECTICUT: Insurers Dropping Out of Medicaid Program In Response to Disclosure Policy More |
Pharma Watch
Industry Group Letter Indicates Qualified Support for Bill To Allow Approval of Generic Biotechnology Medications More
Another Breach of Employee Data at Pfizer More
Peter Rost vs. Pfizer: The Feds Back His Argument More
Merck and Generics Maker Ranbaxy Tie Research Knot More
UK Drugmakers Unveil A New Code Of Conduct More
Pharma Industry Group Favors Obama as Next President More
Global Market Expected to Drive Cancer Drug Growth More
Cancer Study Bonanza Reveals Likely Winners More
|
Fraud & Abuse
Merck Agrees to $58M Settlement Over Vioxx Ad Claims More
Biovail Agrees to Pay $24.6 Million To Settle Probe of Doctor Payments More
Firm Settles With Justice for Manipulating Manufacturing Data More
|
Prices & Health Care Costs
Abbott Worried Norvir Pricing Would Attract Feds More
Average 2008 Employee Out-of-Pocket Costs for Family Health Care To Increase 10.5%, According to Milliman Index More
Consumer Reports Finds That Some Drug Prices Can Vary By $100 or More for the Same Bottle of Pills More
Study: Over Half of Americans on Chronic Medicines More
|
Generics & Patent Policy
Drug Company Payoffs to Stall Generics Under U.S. Government Scrutiny More
Generic Drug Prices Decline More
Chinese Drugs Seen Driving Down Generic Prices More
Europe Expanding Inquiry on Availability of Drugs More
Class Claims GlaxoSmithKline Unlawfully
Extended Monopoly to Boost Wellbutrin Sales More
USPTO Confirms Validity of Lipitor Patent More
|
Conflicts of Interest
After Negative AHRQ Review, Medicare May OK Drug Guide with Non-Disclosure Disclosures More
Doctors moving to limit gifts from drug firms More
|
Advertising & Marketing
Senate Revises Bill That Would Require Drug, Medical Device Makers To Publicly Report Payments, Gifts to Physicians More
Dial FDA: Marketers Face Added DTC Requirements More
GAO Criticizes FDA Regulatory Letters on Violative DTC Ads More
AARP Submits Testimony On DTC Advertising More
FDA Should Review Potentially Deceiving Television Advertisements for
Johnson & Johnson Stent, NEJM Opinion Piece Says More
Product Placements Require New FDA Regs More
So Long Samples, and Other Stories More
Proposed Federal Rule Would Ban Certain Marketing Techniques for Private Medicare Plans More
Drug Company Executives Respond to Concerns About Ads at House Panel Hearing More
Disclosing Drug Makers Payments to Docs Gets Boost More
Medical Journal's Article Questions TV Ads for Stent More |
PBM Watch
Cost-Conscious Insurers Limit Expensive Newer Drugs More
Oakland County Sues Blue Cross Blue Shield More
|
Medicare
CMS Tries Again to Require Lower Part D Prices More
CMS Officials Discuss Ways To Increase Low-Income Subsidy Enrollment in Medicare Drug Benefit More
Lawmakers Criticize Agencies for Lack of Coordination of Prescription Drug Benefits for Federal Retirees More
CMS to Regulate Agent Commission for MA Plans More
Medicare, Federal Retirees Pay for Duplicate Drug Coverage More
|
Medicaid
Democrats Agree on Budget Plan That Avoids the Biggest Decisions More
Insurers Dropping Out of Connecticut Medicaid Program In Response to Disclosure Policy More
|
Safety & Clinical Trials
Consumer Reports Best Buy Drugs Releases Report on Safe and Effective Opioid Painkillers More
Congressional Leaders, Bush Administration, Supporters Respond to FDA's
Request for $275M To Ensure Safety of Imported Medical Devices, Drugs,
Food More
Fighting Back Against "The Constant Gardener" Perception More
F.D.A. Plan on Medical Articles Takes More Heat More
Sanofi-Aventis Wants F.D.A. to Reconsider Heart Drug More
Bayer Antibleeding Drug Takes Hit More
Vioxx Verdict Against Merck Is Overturned More
Glaxo Downplayed Early Warning About AIDS Drug More
F.D.A. Chief Writes Congress for Money More
For the Ill, Guidance in Finding a Clinical Trial More
Dennis Quaid Goes to Washington More
Washington Post Series Examines Errors in Psychiatric Diagnoses, Medications of Detained Immigrants More
FDA Issues Heparin Alerts, Withholds Information from Congress More
FDA Issues Updated Heparin Alerts to Medical Facilities More
FDA Developing Rules For Clinical Trial Oversight More
Justice Department Requests Data on Schering's Vytorin More
FDA Renews a Warning Of Transplant-Drug Risks More
|
Confidentiality
Senate Leaders Agree On Privacy Protections Amendment to Health Care Information Technology Bill More
AMA Officials Outline Provisions Physicians Would Accept in Electronic Prescribing Legislation More
|
Importation & Trade
Corporations Dominate Trade Panels that Set Global Health Policy: Public Health Groups Sue US Government for Fair & Democratic Representation More
U.S. Could Ban Some China Exporters More
|
Upcoming Conferences
12th Annual 340B Coalition Conference More
2008 International Symposium on Pharmaceuticals in the Home and Environment: Catalysts for Change More
|
Healthcare Fellowships
Announcement of the Packer Policy Health Fellowship More
|
Research Tools
Selected Kaiser Research Tools More
Nature Grants Free Access for Biomedical Journals More
|
